Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2024-11-21 00:00:00 ET · period of report 2024-11-20 · accession 0001493152-24-047094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-21 | 2024-11-20 | AIM | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.2 | +85.0K | 1.64M | +5% | +$17.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-20 | P | A | 85,000 | $0.2 | 1,637,968 | D | — | — |